Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

OXB and Santen to develop gene therapy products for retinal disease

pharmaceutical-technologyJune 27, 2019

Tag: OXB , Santen , retinal disease

PharmaSources Customer Service